These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16672186)

  • 1. Safety considerations for operating room personnel during hyperthermic intraoperative intraperitoneal chemotherapy perfusion.
    González-Bayón L; González-Moreno S; Ortega-Pérez G
    Eur J Surg Oncol; 2006 Aug; 32(6):619-24. PubMed ID: 16672186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for management of the peritoneal surface component of cancer: cytoreductive surgery plus perioperative intraperitoneal chemotherapy.
    Sugarbaker PH; Stuart OA; Yoo D
    J Oncol Pharm Pract; 2005 Sep; 11(3):111-9. PubMed ID: 16390599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intraoperative (hyperthermic) intraperitoneal chemotherapy--considerations and aspects of safe intra- and postoperative treatment with cytostatic drugs].
    Jähne J; Piso P; Schmoll E; Haulitschek-Hauss R; Sterzenbach H; Paul H; Pichlmayr R
    Langenbecks Arch Chir; 1997; 382(1):8-14. PubMed ID: 9157234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technology of hyperthermic intraperitoneal chemotherapy in the United States, Europe, China, Japan, and Korea.
    Esquivel J
    Cancer J; 2009; 15(3):249-54. PubMed ID: 19556912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC): evaluation, prevention and policies to avoid occupational exposure for operating room personnel].
    Simon L; Halilou MC; Gladieff L; Gadiou M; Herin F; Hennebelle I; Chatelut E; Ferron G
    Bull Cancer; 2009 Oct; 96(10):971-7. PubMed ID: 19762323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of gastric resections during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.
    Piso P; Slowik P; Popp F; Dahlke MH; Glockzin G; Schlitt HJ
    Ann Surg Oncol; 2009 Aug; 16(8):2188-94. PubMed ID: 19408049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of environmental contamination by platinum and exposure risks for healthcare workers during a heated intraperitoneal perioperative chemotherapy (HIPEC) procedure.
    Konate A; Poupon J; Villa A; Garnier R; Hasni-Pichard H; Mezzaroba D; Fernandez G; Pocard M
    J Surg Oncol; 2011 Jan; 103(1):6-9. PubMed ID: 20886552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperthermic intraperitoneal chemotherapy: methodology and safety considerations.
    González-Moreno S; González-Bayón L; Ortega-Pérez G
    Surg Oncol Clin N Am; 2012 Oct; 21(4):543-57. PubMed ID: 23021715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis.
    Nesher E; Greenberg R; Avital S; Skornick Y; Schneebaum S
    Isr Med Assoc J; 2007 Nov; 9(11):787-90. PubMed ID: 18085034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperthermic intraperitoneal chemotherapy: nomenclature and modalities of perfusion.
    Glehen O; Cotte E; Kusamura S; Deraco M; Baratti D; Passot G; Beaujard AC; Noel GF
    J Surg Oncol; 2008 Sep; 98(4):242-6. PubMed ID: 18726885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic and cardiovascular problems during modified hyperthermic intraperitoneal perioperative chemotherapy.
    Rankovic VI; Masirevic VP; Pavlov MJ; Ceranic MS; Milenkovic MG; Simic AP; Kecmanovic DM
    Hepatogastroenterology; 2007 Mar; 54(74):364-6. PubMed ID: 17523275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Learning curve in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Moradi BN; Esquivel J
    J Surg Oncol; 2009 Sep; 100(4):293-6. PubMed ID: 19697425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Nonaka D; Oliva GD; Laterza B; Deraco M
    Ann Surg Oncol; 2007 Oct; 14(10):2790-7. PubMed ID: 17661150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
    Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
    In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy with paclitaxel: a clinical and pharmacokinetic study.
    de Bree E; Rosing H; Filis D; Romanos J; Melisssourgaki M; Daskalakis M; Pilatou M; Sanidas E; Taflampas P; Kalbakis K; Beijnen JH; Tsiftsis DD
    Ann Surg Oncol; 2008 Apr; 15(4):1183-92. PubMed ID: 18239973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy.
    Kusamura S; Dominique E; Baratti D; Younan R; Deraco M
    J Surg Oncol; 2008 Sep; 98(4):247-52. PubMed ID: 18726886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
    Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy.
    Younan R; Kusamura S; Baratti D; Cloutier AS; Deraco M
    J Surg Oncol; 2008 Sep; 98(4):253-7. PubMed ID: 18726887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reported impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity.
    Sugarbaker PH
    Ann Surg Oncol; 2008 Jun; 15(6):1800-1; author reply 1802-3. PubMed ID: 18196342
    [No Abstract]   [Full Text] [Related]  

  • 20. Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Cabras AD; Dileo P; Laterza B; Deraco M
    Ann Surg Oncol; 2009 Feb; 16(2):463-72. PubMed ID: 19082859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.